Gawdat and colleagues (2022) randomised 20 people with mild-to-moderate neck laxity to two groups. One group had three sessions of fractional RF microneedling with PRP. The other had three sessions of RF microneedling alone. The needles were insulated, meaning the heat is released from the tip and the surface layer of skin is largely spared.
They measured dermal thickness with optical coherence tomography, plus the neck angle, blinded global assessment and patient satisfaction.
Both groups improved significantly on all parameters. Mean dermal thickness was higher in the PRP group, but the difference between the groups was not statistically significant. Global assessment favoured PRP.
The authors wrote that it "remains questionable whether combining fr-RF microneedling with PRP provides more favorable results in terms of efficacy and side effects."
That is the whole direct evidence base: one trial, 20 people, one body area, negative on its objective main measure. There is no adequately powered evidence that adding PRP to RF microneedling improves outcomes.
If you search for microneedling and PRP you will find much more than one small trial. Almost all of it used mechanical microneedling — needles alone, no radiofrequency.
That literature is genuinely mixed. A systematic review and meta-analysis of PRP for scars (Ebrahimi 2022) pooled 13 randomised trials and reported that PRP added to microneedling gave a marked response in 43% and an excellent response in 23% of cases — while opening with the statement that "there is no convincing evidence supporting its use". A network meta-analysis of 24 randomised trials in 1,546 people (Li 2024) found microneedling plus PRP was actually outperformed by microneedling plus a chemical peel.
Mechanical microneedling and RF microneedling injure the skin in different ways, so results from one do not automatically apply to the other. Anyone quoting acne-scar figures to justify PRP with RF microneedling is transferring evidence across device types.
This is a leading reason the research is inconsistent.
PRP is made by spinning your blood and separating the platelet-rich fraction. How much of it you get, and how concentrated it is, depends on the kit, the spin protocol and the person's own blood. A 2021 review of clinic data (Inyang and colleagues) found that FDA-cleared devices produced PRP of inconsistent composition.
So "PRP" is not one thing. Two clinics can both offer PRP and be delivering meaningfully different products, which makes trial results hard to compare and hard to reproduce.
This is widely misstated, so it is worth being precise.
Aesthetic PRP is an off-label use. That is legal and routine, and off-label is not a warning sign in itself. But "PRP is FDA-approved" is not accurate, and neither is "the kits are FDA-approved" — they are cleared, for something else.
Separately, because PRP involves handling blood, facility standards matter. A 2024 MMWR report described presumptive HIV transmission among clients of an unlicensed spa offering PRP microneedling facials in New Mexico, where infection control was not followed and client records were not kept. The lesson there is about licensing and sterile technique, not about the biology of PRP.
RF microneedling leaves thousands of open channels in the skin for a short period. What is applied into them is not a trivial question.
A 2025 systematic review (Friedmann and colleagues) collected 13 studies describing 15 patients who developed granulomatous reactions — persistent inflammatory lumps — after microneedling. Motorised microneedling pens and topical vitamin C were implicated in most cases. Improvement was inconsistent across steroids, antibiotics and anti-inflammatory drugs, so these reactions can be hard to treat.
Those cases were mostly mechanical microneedling, not RF. The transferable lesson is about the general principle: products applied into fresh channels can cause a reaction. PRP is autologous — it is your own blood, not a foreign product — which is a genuine point in its favour compared with off-the-shelf serums.
PRP is a plausible add-on with a good safety profile and no proven incremental benefit for RF microneedling. Reasonable questions to ask are what it costs on top, what the clinic expects it to add, and whether they can point to evidence in RF microneedling specifically rather than mechanical microneedling.
One more piece of context: a split-face trial (Estupinan 2025) compared topical exosomes on one side of the face with PRP on the other, with both sides receiving RF microneedling. The two were equivalent on clinical measures and on biopsy. That tells you exosomes are not better than PRP. It does not tell you either one beats RF microneedling on its own.
If you get cold sores, tell the clinic when you book rather than on the day. Antiviral medicine is started in advance, so it has to be arranged ahead of the appointment. There is no published cold sore data specific to radiofrequency microneedling — the precaution is carried over from laser resurfacing, where reactivation is well documented.